Search

Your search keyword '"Denosumab -- Forecasts and trends -- Reports"' showing total 3 results
Start Over Descriptor "Denosumab -- Forecasts and trends -- Reports" Journal plus company updates
3 results on '"Denosumab -- Forecasts and trends -- Reports"'

1. Global Osteoporosis Drugs Market to Reach $17.52 Billion by 2030

Subjects
Medical research -- Forecasts and trends -- Reports, Medicine, Experimental -- Forecasts and trends -- Reports, Denosumab -- Forecasts and trends -- Reports, Osteoporosis -- Drug therapy, Drugs -- Prescribing, Risk assessment -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Osteoporosis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis' report has [...]

Published
2023

2. Outlook on the World's Osteoporosis Drugs Market to 2025: Data on Bisphosphonates, PTH, SERM, Rank Ligand Inhibitors, Biosimilars, and More

Subjects
Phosphonates -- Market research -- Rankings -- Forecasts and trends -- Reports, Denosumab -- Forecasts and trends -- Reports, Osteoporosis -- Forecasts and trends -- Reports, Parathyroid hormones -- Forecasts and trends -- Reports, Hormone replacement therapy -- Forecasts and trends -- Reports, Market research -- Forecasts and trends -- Reports, Postmenopausal women -- Forecasts and trends -- Reports, Abaloparatide -- Market research -- Rankings -- Forecasts and trends -- Reports, Estrogens -- Forecasts and trends -- Reports, Hormones, Drugs, Phenols (Class of compounds), Marketing research, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, [...]

Published
2019

3. Global Osteoporosis Market & Drug Outlook 2017-2027: Current Market Leader Prolia Will Make Way for New Anabolic Therapies

Subjects
Denosumab -- Forecasts and trends -- Reports, Osteoporosis -- Forecasts and trends -- Reports, Bazedoxifene -- Forecasts and trends -- Reports, Conjugated estrogens -- Forecasts and trends -- Reports, Abaloparatide -- Forecasts and trends -- Reports, Generic drugs -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary, Evenity (Medication) -- Reports, Prolia (Medication) -- Reports
Abstract

Dublin: Research and Markets has issued the following press release: The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been added to ResearchAndMarkets.com's offering. Despite being a [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results